SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001213900-24-006637
Filing Date
2024-01-26
Accepted
2024-01-25 20:04:16
Documents
16
Period of Report
2023-11-16
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 8-K ea192147-8ka1_abvcbio.htm   iXBRL 8-K/A 28732
2 CONSENT OF WWC, P.C ea192147ex23-1_abvcbio.htm EX-23.1 2330
3 AUDITED FINANCIAL STATEMENTS OF AIBL FOR THE PERIOD FROM JANUARY 10, 2023 UNTIL ea192147ex99-1_abvcbio.htm EX-99.1 59844
4 UNAUDITED PRO FORMA CONDENSED COMBINED STATEMENT OF OPERATIONS OF THE COMPANY AN ea192147ex99-2_abvcbio.htm EX-99.2 91951
5 GRAPHIC ex99-1_001.jpg GRAPHIC 6724
  Complete submission text file 0001213900-24-006637.txt   387214

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE abvc-20231116.xsd EX-101.SCH 3021
7 XBRL LABEL FILE abvc-20231116_lab.xml EX-101.LAB 34240
8 XBRL PRESENTATION FILE abvc-20231116_pre.xml EX-101.PRE 22363
10 EXTRACTED XBRL INSTANCE DOCUMENT ea192147-8ka1_abvcbio_htm.xml XML 3886
Mailing Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538
Business Address 44370 OLD WARM SPRINGS BLVD. FREMONT CA 94538 510-668-0881
ABVC BIOPHARMA, INC. (Filer) CIK: 0001173313 (see all company filings)

IRS No.: 260014658 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-40700 | Film No.: 24563804
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)